logo
Quick Facts
Plus   Neg
Share
Email

Nasdaq Ventures Invests In Matter - Quick Facts

By RTTNews Staff Writer   ✉   | Published:

Nasdaq Ventures, Nasdaq's (NDAQ) investment arm, announced a strategic investment in Copenhagen-based Matter, extending and complementing its existing partnership via Nasdaq's European data business. The terms of the deal were not disclosed.

Niels Fibæk-Jensen, CEO of Matter, said: "The investment will enable us to continue the expansion of our sustainability analysis and reporting solutions for financial institutions."

Matter is a leading provider of ESG analysis and reporting tools. The Nasdaq ESG Footprint solution is powered by Matter's analytics technology.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
FDA Accelerates Efforts To Issue EUA For More COVID-19 Home Tests
The U.S. Food and Drug Administration is hastening its efforts to make available more at-home testing options in response to the ongoing COVID-19 pandemic. All At-Home Covid-19 Tests being used now are authorized only for emergency use, and not cleared or fully approved by the FDA. The recent granting of EUA for the Quidel Corp.'s QuickVue At-Home COVID-19 Test is one example.
Dollar Tree, Wendy's Q4 Revenues Miss Estimates
Dollar Tree Inc. (DLTR) Wednesday reported a profit for the fourth-quarter that climbed 309 percent from last year, while Wendy's Co. (WEN) posted a profit that grew about 46.0 percent from the prior year. Dollar Tree has increased its share repurchase authorization by $2.0 billion. Wendy's expects profit for fiscal year 2021 to be below analysts' expectations.
Boston Scientific To Buy Global Surgical Business Of Lumenis For $1.07 Bln Cash - Quick Facts
Medical devices company Boston Scientific Corp. (BSX) agreed Wednesday to acquire the global surgical business of Israel-based Lumenis LTD from an affiliate of Baring Private Equity Asia (BPEA) for an upfront cash payment of $1.07 billion, subject to closing adjustments. Lumenis is a privately-held...
Latest Updates on COVID-19
Read More
COVID-19: Drugs in Development
Follow RTT
Copyright © 2021 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap